|
|
|
|
| LEADER |
05830nam a2200649 4500 |
| 001 |
ocn798534225 |
| 003 |
OCoLC |
| 005 |
20170124065846.2 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
120709s2012 nju ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCO
|d N$T
|d DG1
|d YDXCP
|d OCLCQ
|d OCLCF
|d GWM
|d RECBK
|d OCLCQ
|d OCLCO
|d OCLCQ
|d COO
|d OCLCQ
|d DEBBG
|d GrThAP
|
| 019 |
|
|
|a 865012471
|
| 020 |
|
|
|a 9781118347867
|q (electronic bk.)
|
| 020 |
|
|
|a 1118347862
|q (electronic bk.)
|
| 020 |
|
|
|a 9781118347836
|q (electronic bk.)
|
| 020 |
|
|
|a 1118347838
|q (electronic bk.)
|
| 020 |
|
|
|a 9781118347850
|q (electronic bk.)
|
| 020 |
|
|
|a 1118347854
|q (electronic bk.)
|
| 020 |
|
|
|z 9781118149652
|q (cloth)
|
| 028 |
0 |
1 |
|a EB00066742
|b Recorded Books
|
| 029 |
1 |
|
|a AU@
|b 000049858930
|
| 029 |
1 |
|
|a DEBBG
|b BV042795371
|
| 029 |
1 |
|
|a NZ1
|b 15900837
|
| 029 |
1 |
|
|a DEBBG
|b BV043394654
|
| 035 |
|
|
|a (OCoLC)798534225
|z (OCoLC)865012471
|
| 050 |
|
4 |
|a RM300
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.7/040724
|a 615.7040724
|
| 049 |
|
|
|a MAIN
|
| 100 |
1 |
|
|a Dasgupta, Amitava,
|d 1958-
|
| 245 |
1 |
0 |
|a Resolving erroneous reports in toxicology and therapeutic drug monitoring :
|b a comprehensive guide /
|c Amitava Dasgupta.
|
| 264 |
|
1 |
|a Hoboken :
|b John Wiley & Sons,
|c 2012.
|
| 300 |
|
|
|a 1 online resource (696 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Chapter 1 An Introduction to Tests Performed in Toxicology Laboratories; 1.1. INTRODUCTION; 1.2. ACETAMINOPHEN AND SALICYLATE ASSAYS; 1.3. ANALYSIS OF ALCOHOL; 1.4. THERAPEUTIC DRUG MONITORING; 1.5. ANALYTICAL METHODS USED FOR THERAPEUTIC DRUG MONITORING; 1.6. TESTING OF DRUGS OF ABUSE; 1.7. METHODS USED FOR TESTING OF DRUGS OF ABUSE; 1.8. CONCLUSIONS; Chapter 2 Challenges in Drugs of Abuse Testing; 2.1. INTRODUCTION; 2.2. WORKPLACE DRUG TESTING; 2.3. CHALLENGES OF MEDICAL VERSUS WORKPLACE DRUG TESTING; 2.4. CUT-OFF CONCENTRATIONS.
|
| 505 |
8 |
|
|a 2.5. DRUGS NOT DETECTED IN DRUGS OF ABUSE TESTING PANELS2.6. ADULTERATION OF SPECIMENS AND NEGATIVE DRUGS OF ABUSE SCREEN; 2.7. DRUG TESTING IN ALTERNATIVE SPECIMENS; 2.8. CONCLUSIONS; Chapter 3 False-Positive Results Using Immunoassays for Drugs of Abuse Testing; 3.1. INTRODUCTION; 3.2. INTERFERENCES IN AMPHETAMINE IMMUNOASSAY; 3.3. INTERFERENCES WITH OPIATE IMMUNOASSAY; 3.4. FALSE-POSITIVE TEST RESULTS IN OTHER DRUGS OF ABUSE IMMUNOASSAYS; 3.5. CONCLUSIONS; Chapter 4 True-Positive Drugs of Abuse Test Results Due to Use of Prescriptions and Nonprescription Drugs; 4.1. INTRODUCTION.
|
| 505 |
8 |
|
|a 4.2. POSITIVE AMPHETAMINE/METHAMPHETAMINE TEST RESULT4.3. TRUE-POSITIVE MARIJUANA RESULT; 4.4. TRUE-POSITIVE OPIATE TESTS DUE TO USE OF MEDICATIONS AND INGESTION OF PRODUCTS CONTAINING POPPY SEEDS; 4.5. TRUE-POSITIVE BENZODIAZEPINE TEST RESULTS; 4.6. VARIOUS FACTORS THAT PRODUCE A POSITIVE COCAINE RESULT; 4.7. CONCLUSIONS; Chapter 5 When Toxicology Report Is Negative in a Suspected Overdosed Patient: The World of Designer Drugs; 5.1. INTRODUCTION; 5.2. AMPHETAMINE-TYPE DESIGNER DRUGS; 5.3. OPIOID DESIGNER DRUG; 5.4. PHENCYCLIDINE ANALOGS AS DESIGNER DRUGS; 5.5. GHB AND ITS ANALOGS.
|
| 505 |
8 |
|
|a 5.6. MARIJUANA ANALOGS AS DESIGNER DRUGS5.7. CONCLUSIONS; Chapter 6 Abuse of Magic Mushrooms, Peyote Cactus, Khat, and Solvents: No Readily Available Laboratory Tests; 6.1. INTRODUCTION; 6.2. MAGIC MUSHROOM ABUSE; 6.3. PEYOTE CACTUS: USE AND ABUSE; 6.4. ABUSE OF KHAT AND RELATED COMPOUNDS; 6.5. SOLVENT AND GLUE ABUSE; 6.6. CONCLUSIONS; Chapter 7 Limitations of Blood Alcohol Measurements Using Automated Analyzers and Breath Analyzers; 7.1. INTRODUCTION; 7.2. ALCOHOL METABOLISM; 7.3. MODERATE DRINKING VERSUS ALCOHOL ABUSE; 7.4. BLOOD ALCOHOL DETERMINATION.
|
| 505 |
8 |
|
|a 7.5. BREATH ALCOHOL VERSUS BLOOD ALCOHOL DETERMINATION7.6. BLOOD ALCOHOL DETERMINATION; 7.7. CONCLUSIONS; Chapter 8 Role of the Laboratory in Detecting Other Poisoning, Including Pesticides, Ethylene Glycol, and Methanol; 8.1. INTRODUCTION; 8.2. PESTICIDE POISONING; 8.3. ORGANOPHOSPHATE AND CARBAMATE POISONING: MECHANISM OF POISONING AND SYMPTOMS; 8.4. CHALLENGES IN USING CHOLINESTERASE AS A DIAGNOSTIC TEST FOR ORGANOPHOSPHATE AND CARBAMATE POISONING; 8.5. METHANOL USE AND METHANOL POISONING; 8.6. ETHYLENE GLYCOL USE AND ETHYLENE GLYCOL POISONING; 8.7. CONCLUSIONS.
|
| 500 |
|
|
|a Chapter 9 Poisoning with Warfarin and Superwarfarin: What Can Laboratory Testing Do?
|
| 520 |
|
|
|a The tools for detecting false positives, false negatives, and interference in interactions when testing and monitoring therapeutic drug useFor physicians monitoring a patient's progress, efficacy of treatment is often linked to a patient's response to medication. Determining whether a patient is taking the prescribed amount, the drug or dosage is effective, or the prescribed medication is interacting with other drugs can be determined through drug testing. Written as a guide for toxicologists, chemists, and health professionals involved in patient care, Resolving Erroneous Reports in Toxicolog.
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Drug monitoring.
|
| 650 |
|
0 |
|a Drugs
|x Toxicity testing.
|
| 650 |
|
4 |
|a Medicine.
|
| 650 |
|
4 |
|a Pharmacy.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug monitoring.
|2 fast
|0 (OCoLC)fst00898688
|
| 650 |
|
7 |
|a Drugs
|x Toxicity testing.
|2 fast
|0 (OCoLC)fst00898957
|
| 655 |
|
4 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|a Dasgupta, Amitava.
|t Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring : A Comprehensive Guide.
|d Hoboken : John Wiley & Sons, ©2012
|z 9781118149652
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118347867
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
